| Followers | 2422 |
| Posts | 92347 |
| Boards Moderated | 1 |
| Alias Born | 09/12/2003 |
Thursday, July 02, 2020 2:25:39 PM
It get the message out that is the bottom line. Regardless on how you looks the company issue news cost them money, it's not free that is marketing/promo the company. Same chit just different way of doing things.
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM

